info@targetmol.com    Tel: (857) 239-0968 / (617) 419-7131
Home > Immunology/Inflammation > HDAC > BML-210
BML-210  
Catalog No. T3204    CAS 537034-17-6
Pack Size
Availability
Price/USD
Quantity
5mg
In Stock
69.00
25mg
In Stock
299.00
50mg
In Stock
473.00
10mM * 1mL (in DMSO)
In Stock
77.00
10mg
In Stock
106.00
Bulk Size: Please Quote for Discount
Documents and Quality Management
Purity:99.00% COA Datasheet HNMR MSDS
Biological Activity:

Product Description:

BML-210 is the novel HDAC inhibitor, and its mechanism of action has not been characterized.

Target:
HDAC;
Research Area:
Cancer
Chemical Information:
Molecular Weight 339.43
Formula C20H25N3O2
CAS Number 537034-17-6
Solubility DMSO: ≥ 30 mg/mL
Storage 3 years -20°C powder;
2 years -80°C in solvent;
Remark For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ℃ for several month.
Technical Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.

Related Compound Libraries
This product is contained In the following compound libraries:
Product Recommendations
  • FGF401,

    FGF-401 is an inhibitor of FGFR4 extracted from patent WO2015059668A1, compound example 83; has a...

  • 4-Oxofenretinide, 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arre...
  • Gemcitabine monophosphate, Gemcitabine monophosphate disodium salt, also called GemMP, is a monophosphate derivative of Gemcita...
  • Repertaxin, Reparixin is a potent inhibitor of both CXCL8 receptors?CXCR1/2, it inhibits weakly?CXCR2-mediated c...
  • Goserelin acetate,

    Goserelin (ICI 118630) acetate is an injectable gonadotropin releasing hormone superagonist (GnRH...

 

Reference

If you have additional questions, Please send us a message. * Required